Should CoverMyMeds prioritize expanding its electronic prior authorization platform to more specialties or focus on improving the user experience for existing specialties?

Introduction

The trade-off we're examining today is whether CoverMyMeds should prioritize expanding its electronic prior authorization platform to more specialties or focus on improving the user experience for existing specialties. This decision is crucial for the company's growth strategy and user satisfaction. I'll analyze this trade-off by considering the product's current state, potential impacts, key metrics, and experimental approaches to guide our decision-making process.

Step 1

Clarifying Questions (3 minutes)

• Based on the current market position, I'm thinking our expansion strategy might be influenced by competitive pressures. Could you share insights on our market share in existing specialties versus potential new ones?

Why it matters: Helps determine if we should defend our current position or aggressively expand Expected answer: Strong in current specialties, but untapped potential in new ones Impact on approach: Would influence resource allocation between improvement and expansion

• Considering user feedback, I'm assuming we have data on pain points in our current platform. Can you provide an overview of the most critical user experience issues we're facing?

Why it matters: Identifies the urgency and potential impact of UX improvements Expected answer: Several key issues affecting user satisfaction and efficiency Impact on approach: Would help prioritize UX improvements against expansion benefits

• Looking at our technical infrastructure, I'm curious about our platform's scalability. How easily can we integrate new specialties without compromising system performance?

Why it matters: Assesses the technical feasibility and cost of expansion Expected answer: Moderately scalable with some required infrastructure upgrades Impact on approach: Would influence the timeline and resource requirements for expansion

• Regarding our business model, I'm wondering about the revenue potential of new specialties versus optimizing existing ones. Can you share any projections on revenue growth for both scenarios?

Why it matters: Aligns the decision with financial goals and investor expectations Expected answer: Higher short-term gains from optimization, but larger long-term potential from expansion Impact on approach: Would affect the balance between short-term results and long-term strategy